Morange PE - Search Results

1

DNA methylation analysis is used to identify novel genetic loci associated with circulating fibrinogen levels in blood.

Hahn J, Bressler J, Domingo-Relloso A, Chen MH, McCartney DL, Teumer A, van Dongen J, Kleber ME, Aïssi D, Swenson BR, Yao J, Zhao W, Huang J, Xia Y, Brown MR, Costeira R, de Geus EJC, Delgado GE, Dobson DA, Elliott P, Grabe HJ, Guo X, Harris SE, Huffman JE, Kardia SLR, Liu Y, Lorkowski S, Marioni RE, Nauck M, Ratliff SM, Sabater-Lleal M, Spector TD, Suchon P, Taylor KD, Thibord F, Trégouët DA, Wiggins KL, Willemsen G, Bell JT, Boomsma DI, Cole SA, Cox SR, Dehghan A, Greinacher A, Haack K, März W, Morange PE, Rotter JI, Sotoodehnia N, Tellez-Plaza M, Navas-Acien A, Smith JA, Johnson AD, Fornage M, Smith NL, Wolberg AS, Morrison AC, de Vries PS. Hahn J, et al. Among authors: morange pe. J Thromb Haemost. 2023 May;21(5):1135-1147. doi: 10.1016/j.jtha.2023.01.015. Epub 2023 Jan 28. J Thromb Haemost. 2023. PMID: 36716967 Free PMC article.

2

The A -844G polymorphism in the PAI-1 gene is associated with a higher risk of venous thrombosis in factor V Leiden carriers.

Morange PE, Henry M, Tregouët D, Granel B, Aillaud MF, Alessi MC, Juhan-Vague I. Morange PE, et al. Arterioscler Thromb Vasc Biol. 2000 May;20(5):1387-91. doi: 10.1161/01.atv.20.5.1387. Arterioscler Thromb Vasc Biol. 2000. PMID: 10807758

3

Combined segregation-linkage analysis of plasma thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels with TAFI gene polymorphisms.

Trégouet DA, Aubert H, Henry M, Morange P, Visvikis S, Juhan-Vague I, Tiret L. Trégouet DA, et al. Hum Genet. 2001 Aug;109(2):191-7. doi: 10.1007/s004390100558. Hum Genet. 2001. PMID: 11511925

4

Weak and non-independent association between plasma TAFI antigen levels and the insulin resistance syndrome.

Aubert H, Frère C, Aillaud MF, Morange PE, Juhan-Vague I, Alessi MC. Aubert H, et al. Among authors: morange pe. J Thromb Haemost. 2003 Apr;1(4):791-7. doi: 10.1046/j.1538-7836.2003.00147.x. J Thromb Haemost. 2003. PMID: 12871417 Free article.

5

Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort.

Morange PE, Tregouet DA, Frere C, Saut N, Pellegrina L, Alessi MC, Visvikis S, Tiret L, Juhan-Vague I. Morange PE, et al. Br J Haematol. 2005 Jan;128(1):91-9. doi: 10.1111/j.1365-2141.2004.05275.x. Br J Haematol. 2005. PMID: 15606554 Free article.

6

TAFI gene haplotypes, TAFI plasma levels and future risk of coronary heart disease: the PRIME Study.

Morange PE, Tregouet DA, Frere C, Luc G, Arveiler D, Ferrieres J, Amouyel P, Evans A, Ducimetiere P, Cambien F, Tiret L, Juhan-Vague I; Prime Study Group. Morange PE, et al. J Thromb Haemost. 2005 Jul;3(7):1503-10. doi: 10.1111/j.1538-7836.2005.01486.x. J Thromb Haemost. 2005. PMID: 15978108 Free article.

7

Fine mapping of quantitative trait nucleotides underlying thrombin-activatable fibrinolysis inhibitor antigen levels by a transethnic study.

Frère C, Tregouet DA, Morange PE, Saut N, Kouassi D, Juhan-Vague I, Tiret L, Alessi MC. Frère C, et al. Among authors: morange pe. Blood. 2006 Sep 1;108(5):1562-8. doi: 10.1182/blood-2006-01-008094. Epub 2006 May 16. Blood. 2006. PMID: 16705091 Free article.

8

Association of plasminogen activator inhibitor (PAI)-1 (SERPINE1) SNPs with myocardial infarction, plasma PAI-1, and metabolic parameters: the HIFMECH study.

Morange PE, Saut N, Alessi MC, Yudkin JS, Margaglione M, Di Minno G, Hamsten A, Humphries SE, Tregouet DA, Juhan-Vague I. Morange PE, et al. Arterioscler Thromb Vasc Biol. 2007 Oct;27(10):2250-7. doi: 10.1161/ATVBAHA.107.149468. Epub 2007 Jul 26. Arterioscler Thromb Vasc Biol. 2007. PMID: 17656673

9

Activated thrombin activatable fibrinolysis inhibitor levels are associated with the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.

Tregouet DA, Schnabel R, Alessi MC, Godefroy T, Declerck PJ, Nicaud V, Munzel T, Bickel C, Rupprecht HJ, Lubos E, Zeller T, Juhan-Vague I, Blankenberg S, Tiret L, Morange PE; AtheroGene Investigators. Tregouet DA, et al. Among authors: morange pe. J Thromb Haemost. 2009 Jan;7(1):49-57. doi: 10.1111/j.1538-7836.2008.03221.x. J Thromb Haemost. 2009. PMID: 19017260 Free article.

10

Polymorphisms of the lamina maturation pathway and their association with the metabolic syndrome: the DESIR prospective study.

Fontaine-Bisson B, Alessi MC, Saut N, Fumeron F, Marre M, Dutour A, Badens C, Levy N, Tichet J, Juhan-Vague I, Trégouët DA, Balkau B, Morange PE. Fontaine-Bisson B, et al. Among authors: morange pe. J Mol Med (Berl). 2010 Feb;88(2):193-201. doi: 10.1007/s00109-009-0548-y. Epub 2009 Oct 16. J Mol Med (Berl). 2010. PMID: 19841875

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294 results

Search Page

Filters